PartsTable TECHNICAL DATA SHEET
NSN 6505-01-528-6349Government record, cited

Ceftazidime for Injection6505-01-528-6349

NSN 6505-01-528-6349 · NIIN 015286349 · Part number NDC00409-5093-11
Sandoz Inc. · FSC 6505 — Drugs and Biologicals · FSG 65 — Medical, Dental, and Veterinary Equipment · CAGE 0THL4
Government record, cited
NSN 6505-01-528-6349 — this item is cataloged by the U.S. Government under National Stock Number 6505-01-528-6349. Manufacturer of record part number: NDC00409-5093-11.
Also searched as  6505-01-528-6349 · 6505015286349 · NIIN 015286349 · 01-528-6349 · FSC 6505 Drugs and Biologicals · CAGE 0THL4 · NDC00409-5093-11 · 05-0144
Nearby stock numbers  ·
Features
  • Ceftazidime for Injection — FSC 6505
  • Administration: INTRAVENOUS
  • Primary Container Content Quantity: 18.000 MILLILITERS AFTER RECONSTITUTION
  • Supplementary Features: ADDVANTAGE VIALS TO BE USED WITH ADDVANTAGE DILUENT
  • Medical Designation and Grade: UNITED STATES PHARMACOPEIA
  • Features Provided: STERILE
  • Primary Container Type: VIAL
  • Physical Form: POWDER
Identification
  • NSN: 6505-01-528-6349
  • NIIN: 015286349
  • FSC: 6505 — Drugs and Biologicals
  • FSG: 65 — Medical, Dental, and Veterinary Equipment
  • Primary part number: NDC00409-5093-11
  • Manufacturer: Sandoz Inc.
General Description

The Ceftazidime for Injection, cataloged under National Stock Number 6505-01-528-6349, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Sandoz Inc.. Government technical data includes 10 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. 1 item shares a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active. Unit of issue: PG.

Technical Specifications
ParameterValue
NSN6505-01-528-6349
Primary Part NumberNDC00409-5093-11
Item NameCeftazidime for Injection
FSC / FSG6505 / 65 — Drugs and Biologicals
ManufacturerSandoz Inc.
StatusACTIVE
AdministrationINTRAVENOUS
Primary Container Content Quantity18.000 MILLILITERS AFTER RECONSTITUTION
Supplementary FeaturesADDVANTAGE VIALS TO BE USED WITH ADDVANTAGE DILUENT
Medical Designation and GradeUNITED STATES PHARMACOPEIA
Features ProvidedSTERILE
Primary Container TypeVIAL
Physical FormPOWDER
American Hospital Formulary Service Classification Number081206
Active Medicament Medicinal Strength2.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT G
Total Primary Container Quantity10
Lifecycle & Compliance
Acquisition StatusACTIVE
DEMIL CodeDEMIL A — No Demilitarization Required
HazardPossible hazard — SDS may be required (DLA HMIC P)
Criticality CodeX
Unit of IssuePG
⇄ Related Items 1
Each row states its source: a government interchangeability/replacement code, or a possible match on a shared part number.
6530-01-732-564605-0144 POSSIBLE MATCH
COVER,LITTER CARRIER
Possible match (shared part number)Ferno Washington, Inc. Dba Ferno Washington Inc
Cross-Reference Index
Part NumberManufacturer
NDC00409-5093-11 PRIMARY Sandoz Inc. (USA)
Reference documents
ReferenceMeaning
NDC00409-5093-11 3/9 Design control — primary reference
Hospira, Inc.
05-0144 5/1 Secondary reference
U.S. Government activity
NDC00409-5093-11 5/2 Secondary reference
U.S. Government activity
Related Parts
6530-01-732-5646POSSIBLE MATCH
COVER,LITTER CARRIER
05-0144

Frequently Asked Questions

What is NSN 6505-01-528-6349?

NSN 6505-01-528-6349 is a Ceftazidime for Injection, manufactured by Sandoz Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.

What part numbers are listed for NSN 6505-01-528-6349?

NSN 6505-01-528-6349 has 1 manufacturer part number on file: NDC00409-5093-11 (Sandoz Inc.).

What NSN replaces 6505-01-528-6349?

1 possible match (shared part number, not a government interchangeability claim): 6530-01-732-5646. Verify interchangeability with system specifications before substitution.

What are the specifications of NDC00409-5093-11?

Key specifications for NDC00409-5093-11: Administration: INTRAVENOUS; Primary Container Content Quantity: 18.000 MILLILITERS AFTER RECONSTITUTION; Supplementary Features: ADDVANTAGE VIALS TO BE USED WITH ADDVANTAGE DILUENT; Medical Designation and Grade: UNITED STATES PHARMACOPEIA. 10 specifications are documented in the U.S. Government catalog.

Is NSN 6505-01-528-6349 hazardous material?

Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.

Sources

U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.

U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.

✓ Data cited from the U.S. Government catalog; commercial cross-references from OEM and certified industry sources.
PartsTable Design LLC · partstable.com